TP63 and lung cancer: Our results indicate that specific cytogenetic alterations present in preinvasive lung lesions such as amplification or over-representation of the TP63 and MYC genes are highly associated with the diagnosis of lung cancer and therefore suggest a role of those markers in assessing lung cancer risk.